Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > GO KALYTERA GO. JUST WHERE, WE AREN'T SURE YET
View:
Post by losingmyshirt on Mar 20, 2022 2:28pm

GO KALYTERA GO. JUST WHERE, WE AREN'T SURE YET

IF YOU ARE LONG ON KALYTERA OR CLAS AS YOU NOW KNOW IT, YOU ALREADY HAVE A BIG PROBLEM.
YOU DID NOT DO YOUR dd AND YOU ARE TRAPPED ,HOLDING SHARES THAT ARE BASICALLY USELESS.

TAKE A HARD LOOK AT WHAT YOU HAVE DONE. YOU PUT MONEY INTO A COMPANY THAT JUST CANNOT GENERATE ANY VALUE  FOR INVESTORS BECAUSE THEY HAVE NOTHING TO  BRING TO MARKET.

ONLY A [PERNERSHIP OR BUYOUT CAN SAVE YOUR INVESTMENT BUT NO ONE WOULD PARTNER WITH THESE CROOKS. THEY HAVE AN EXCEPTIONALLY POOR TRACK RECORD.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities